MAIA Biotechnology, Inc. · AMEX:MAIA
MAIA Biotechnology, Inc. shareholders
As of Sep 30, 2026, 42 institutions reported holding MAIA Biotechnology, Inc., 19.7% of its shares. Largest: Solas Capital Management, LLC, Vanguard and Centric Wealth Management. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of MAIA Biotechnology, Inc. | Change | Filed |
|---|---|---|---|---|
| Solas Capital Management, LLC | 3.03M | 4.9% | no change | Nov 16, 2026 |
| Vanguard | 2.76M | 4.5% | no change | Nov 13, 2026 |
| Centric Wealth Management | 1.17M | 1.9% | +370K | Nov 12, 2026 |
| 683 Capital Management, LLC | 1.07M | 1.7% | no change | Nov 16, 2026 |
| Geode Capital | 584K | 0.95% | +80,021 | Nov 6, 2026 |
| Cable Car Capital, LP | 515K | 0.83% | no change | Nov 16, 2026 |
| Bleichroeder LP | 500K | 0.81% | no change | Nov 13, 2026 |
| Renaissance Technologies | 399K | 0.65% | −16,600 | Nov 12, 2026 |
| BlackRock | 395K | 0.64% | −8,239 | Nov 13, 2026 |
| Alyeska Investment Group, L.P. | 295K | 0.48% | −2.2M | Nov 16, 2026 |